The FDA has approved a combination of Pfizer’s Braftovi and Merck KGaA’s Erbitux for a form of untreated metastatic colorectal cancer, the first targeted drug regimen for this form of the disease.
If you want to run across rooftops like your favorite anime heroes, but you're stuck with basic champs, our Parkour Champions codes are here to help. Use these codes to grab extra coins and spins to ...
Big news for prostate cancer treatment: a new drug combo—leuprolide plus enzalutamide—cut the risk of death by over 40% in patients with aggressive, recurring cancer, according to the global EMBARK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback